Tobacco Industry Influence on Science and Scientists in Germany
Thilo Grüning, MD, MSc, DEAA,
Anna B. Gilmore, MBBS, MSc, MFPH and
Martin McKee, MD, FRCP
At the time of the study, Thilo Grüning was with the Department of Anaesthesia and Intensive Care, Royal Free Hospital, Royal Free Hampstead NHS Trust, London, England. Anna B. Gilmore and Martin McKee are with the European Centre on Health of Societies in Transition, London School of Hygiene and Tropical Medicine, London.
Correspondence: Requests for reprints should be sent to Thilo Grüning, MD, MSc, DEAA, c/o European Centre on Health of Societies in Transition, London School of Hygiene and Tropical Medicine, Keppel Street, London WC1E 7HT, England (e-mail: t{at}gzzz.freeserve.co.uk).
Using tobacco industry documents, we examined how and why thetobacco industry sought to influence science and scientistsin Germany as a possible factor in explaining the German oppositionto stricter tobacco regulation.
Smoking and health research programs were organized both separatelyby individual tobacco companies and jointly through their Germantrade organization. An extensive network of scientists and scientificinstitutions with tobacco industry links was developed. Sciencewas distorted in 5 ways: suppression, dilution, distraction,concealment, and manipulation.
The extent of tobacco industry influence over the scientificestablishment in Germany is profound. The industry introducedserious bias that probably influenced scientific and publicopinion in Germany. This influence likely undermined effortsto control tobacco use.
This article has been cited by other articles:
A. Landman and S. A. Glantz Tobacco Industry Efforts to Undermine Policy-Relevant Research
Am J Public Health,
January 1, 2009;
99(1):
45 - 58.
[Abstract][Full Text][PDF]
P. Diethelm and M. McKee Denialism: what is it and how should scientists respond?
Eur J Public Health,
January 1, 2009;
19(1):
2 - 4.
[Full Text][PDF]
E. K. Tong and S. A. Glantz Tobacco Industry Efforts Undermining Evidence Linking Secondhand Smoke With Cardiovascular Disease
Circulation,
October 16, 2007;
116(16):
1845 - 1854.
[Abstract][Full Text][PDF]
M. McKee and A. Gilmore Commentary: Smokeless tobacco: seeing the whole picture
Int. J. Epidemiol.,
August 14, 2007;
(2007)
dym101v1.
[Full Text][PDF]
J. R. Lynch, M. R.A. Cunningham, W. J. Warme, D. C. Schaad, F. M. Wolf, and S. S. Leopold Commercially Funded and United States-Based Research Is More Likely to Be Published; Good-Quality Studies with Negative Outcomes Are Not
J. Bone Joint Surg. Am.,
May 1, 2007;
89(5):
1010 - 1018.
[Abstract][Full Text][PDF]
A. Kramer INDEPENDENT RESEARCH ON TOBACCO CONTROL IN GERMANY
Am J Public Health,
June 1, 2006;
96(6):
956 - 957.
[Full Text][PDF]
A Bornhauser, J McCarthy, and S A Glantz German tobacco industry's successful efforts to maintain scientific and political respectability to prevent regulation of secondhand smoke.
Tob. Control,
April 1, 2006;
15(2):
e1 - e1.
[Abstract][Full Text][PDF]